EIP
MED icon

Easterly Investment Partners’s Medifast MED Stock Holding History

Easterly Investment Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,333
Closed -$829K – 225
2023
Q4 		$829K Sell
12,333
-7,045
-36% -$491K 0.09% 143
2023
Q3 		$1.45M Hold
19,378
– – 0.16% 115
2023
Q2 		$1.79M Buy
19,378
+11,563
+148% +$1.03M 0.16% 116
2023
Q1 		$810K Buy
+7,815
New +$866K 0.07% 147

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Easterly Investment Partners's MED Position: Q1 2024 in Review

Easterly Investment Partners sold out of Medifast (MED) in Q1 2024, closing a stake of 12,333 shares — an estimated $829K sold.

Easterly Investment Partners first reported a position in MED in Q1 2023 and held it in 4 quarters. The position peaked at $1.79M in Q2 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Easterly Investment Partners reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Easterly Investment Partners sold 12,333 Medifast shares in Q1 2024, an estimated $829K.
  • Easterly Investment Partners first reported a position in Medifast in Q1 2023 and held it in 4 quarters.
  • Easterly Investment Partners's Medifast position peaked at $1.79M in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Easterly Investment Partners's 13F filing for Q1 2024, filed 3 May 2024.